The role of diet in the prevention of type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue SUPPL. 2, 2011, Pages

  Salas Salvado J ^a,b   Martinez Gonzalez M A ^c   Bullo M ^a,b   Ros, E ^b,d  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Body weight; Carbohydrates; Diabetes; Dietary fat; Dietary patterns; Fiber

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CALORIC INTAKE; CARBOHYDRATE DIET; DIET; DIET THERAPY; FAT INTAKE; FEEDING BEHAVIOR; FOOD PREFERENCE; HUMAN; LIFESTYLE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; FOOD HABITS; FOOD PREFERENCES; HUMANS; LIFE STYLE; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; WEIGHT LOSS;

EID: 80052418316     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.03.009     Document Type: Article

References (200)

1. Standards of medical care in diabetes-2008. Diabetes Care 2008, 31(Suppl. 1):S12-S54. American Diabetes Association.
2. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
3. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997, 20:537-544.
4. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
5. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
6. Kosaka K., Noda M., Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005, 67:152-162.
7. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., Vijay V., et al. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49:289-297.
8. Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlström B., Katsilambros N., et al. Diabetes and nutrition study group (DNSG) of the European association for the study of diabetes (EASD). Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004, 14:373-394.
9. Bantle J.P., Wylie-Rosett J., Albright A.L., Apovian C.M., Clark N.G., Franz M.J., et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl. 1):S61-S78. American Diabetes Association.
10. Buyken A.E., Mitchell P., Ceriello A., Brand-Miller J. Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia 2010, 53(3):406-418.
11. Spence M., McKinley M.C., Hunter S.J. Diet, insulin resistance and diabetes: the right (pro)portions. Proc Nutr Soc 2010, 69:61-69.
12. Risérus U., Willett W.C., Hu F.B. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009, 48:44-51.
13. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195-1200.
14. Willett W.C., Dietz W.H., Colditz G.A. Guidelines for healthy weight. N Engl J Med 1999, 341:427.
15. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001, 345:790-797.
16. Sasai H., Sairenchi T., Iso H., Irie F., Otaka E., Tanaka K., et al. Relationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki Prefectural Health Study. Mayo Clin Proc 2010, 85:36-40.
17. Rana J.S., Li T.Y., Manson J.E., Hu F.B. Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 2007, 30:53-58.
18. Colditz G.A., Willett W.C., Rotnitzky A., Manson J.E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995, 122:481-486.
19. Will J.C., Williamson D.F., Ford E.S., Calle E.E., Thun M.J. Intentional weight loss and 13-year diabetes incidence in overweight adults. Am J Public Health 2002, 92:1245-1248.
20. Lloret-Linares C., Greenfield J.R., Czernichow S. Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes: a review. Diabet Med 2008, 25:1142-1150.
21. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M.D., Pories W.J., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009, 122:248-256.
22. Sjöström C.D., Lissner L., Wedel H., Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999, 7:477-484.
23. Kriska A.M., Blair S.N., Pereira M.A. The potential role of physical activity in the prevention of non-insulin-dependent diabetes mellitus: the epidemiological evidence. Exerc Sport Sci Rev 1994, 22:121-143.
24. Manson J.E., Nathan D.M., Krolewski A.S., Stampfer M.J., Willett W.C., Hennekens C.H. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992, 268:63-67.
25. Yates T., Khunti K., Bull F., Gorely T., Davies M.J. The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 2007, 50:1116-1126.
26. Saaristo T., Moilanen L., Korpi-Hyövälti E., Vanhala M., Saltevo J., Niskanen L., et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 2010, 33(10):2146-2151.
27. Lindström J., Peltonen M., Eriksson J.G., Louheranta A., Fogelholm M., Uusitupa M., et al. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 2006, 49(5):912-920.
28. Laaksonen D.E., Lindström J., Lakka T.A., Eriksson J.G., Niskanen L., Wikström K., et al. Finnish diabetes prevention study. Physical activity in the prevention of type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 2005, 54:158-165.
29. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemiö K., et al. Finnish diabetes prevention study group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet 2006, 368:1673-1679.
30. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371:1783-1789.
31. Knowler W.C., Fowler S.E., Hamman R.F., Christophi C.A., Hoffman H.J., Brenneman A.T., et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686.
32. Uusitupa M., Peltonen M., Lindström J., Aunola S., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., et al. Finnish diabetes prevention study Group. Ten-year mortality and cardiovascular morbidity in the Finnish diabetes prevention Study-secondary analysis of the randomized trial. PLoS One 2009, 4:e5656.
33. Martínez-González M.A., Corella D., Salas-Salvadó J., Ros E., Covas M.I., Fiol M., et al. Cohort Profile: design and methods of the PREDIMED study. Int J Epidemiol 2010 Dec 20, [Epub ahead of print].
34. Salas-Salvadó J., Bulló M., Babio N., Martínez-González M.A., Ibarrola-Jurado N., Basora J., et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011, 34:14-19. PREDIMED Study Investigators.
35. Park S.H., Lee K.S., Park H.Y. Dietary carbohydrate intake is associated with cardiovascular disease risk in Korean: analysis of the third Korea National Health and Nutrition Examination Survey (KNHANES III). Int J Cardiol 2008 Nov 13, [Epub ahead of print].
36. Mohan V., Radhika G., Sathya R.M., Tamil S.R., Ganesan A. Sudha V.Dietary carbohydrates, glycaemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59). Br J Nutr 2009, 102:1498-1506.
37. Schulze M.B., Schulz M., Heidemann C., Schienkiewitz A., Hoffmann K., Boeing H. Carbohydrate intake and incidence of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)-Potsdam study. Br J Nutr 2008, 99:1107-1116.
38. Hodge A.M., English D.R., 'Dea K., Giles G.G. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004, 27:2701-2706.
39. Iqbal S.I., Helge J.W., Heitmann B.L. Do energy density and dietary fiber influence subsequent 5-year weight changes in adult men and women?. Obes (Silver Spring) 2006, 14:106-114.
40. Schulze M.B., Schulz M., Heidemann C., Schienkiewitz A., Hoffmann K., Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007, 167:956-965.
41. Priebe M.G., van Binsbergen J.J., de Vos R., Vonk R.J. Whole grain foods for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 2008, CD006061.
42. Liu S., Willett W.C., Manson J.E., Hu F.B., Rosner B., Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 2003, 78:920-927.
43. Slavin J.L., Martini M.C., Jacobs D.R., Marquart L. Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr 1999, 70:459S-463S.
44. Salas-Salvadó J., Farrés X., Luque X., Narejos S., Borrell M., Basora J., et al. Fiber in Obesity-Study Group. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr 2008, 99:1380-1387.
45. Salmerón J., Ascherio A., Rimm E.B., Colditz G.A., Spiegelman D., Jenkins D.J., et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997, 20:545-550.
46. Salmerón J., Manson J.E., Stampfer M.J., Colditz G.A., Wing A.L., Willett W.C. Dietary fiber, glycemic load and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997, 277:472-477.
47. Meyer K.A., Kushi L.H., Jacobs D.R., Slavin J., Sellers T.A., Folsom A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000, 71:921-930.
48. Montonen J., Knekt P., Järvinen R., Aromaa A., Reunanen A. Whole-grain and fibre intake and the incidence of type 2 diabetes. Am J Clin Nutr 2003, 77:622-629.
49. Krishnan S., Rosenberg L., Singer M., Hu F.B., Djoussé L., Cupples L.A., et al. Glycemic index, glycemic load, and cereal fibre intake and risk of T2DMin US black women. Arch Intern Med 2007, 167:2304-2309.
50. Whole-grain foods in health and disease 2002, American Association of Cereal Chemists, Inc, St Paul, MN. L. Marquart, J.L. Slavin, R.G. Fulcher (Eds.).
51. Samra R.A., Anderson G.H. Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men. Am J Clin Nutr 2007, 86:972-979.
52. Pereira M.A., Jacobs D.R., Pins J.J., Raatz S.K., Gross M.D., Slavin J.L., et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 2002, 75:848-855.
53. Weickert M.O., Möhlig M., Schöfl C., Arafat A.M., Otto B., Viehoff H., et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006, 29:775-780.
54. Chandalia M., Garg A., Lutjohann D., von Bergmann K., Grundy S.M., Brinkley L.J. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000, 342:1392-1398.
55. Weickert M.O., Mohlig M., Koebnick C., Holst J.J., Namsolleck P., Ristow M., et al. Impact of cereal fibre on glucose-regulating factors. Diabetologia 2005, 48:2343-2353.
56. Ma Y., Griffith J.A., Chasan-Taber L., Olendzki B.C., Jackson E., Stanek E.J., et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 2006, 83:760-766.
57. Weickert M.O., Pfeiffer A.F.H. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008, 138:439-442.
58. Barclay A.W., Petocz P., McMillan-Price J., Flood V.M., Prvan T., Mitchell P., et al. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am J Clin Nutr 2008, 87:627-637.
59. Sluijs I., van der Schouw Y.T., van der A.D.L., Spijkerman A.M., Hu F.B., Grobbee D.E., et al. Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL) study. Am J Clin Nutr 2010, 92:905-911.
60. Thomas D., Elliott E.J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst Rev 2009, CD006296.
61. Sunehag A.L., Toffolo G., Treuth M.S., Butte N.F., Cobelli C., Bier D.M., et al. Effects of dietary macronutrient content on glucose metabolism in children. J Clin Endocrinol Metab 2002, 87:5168-5178.
62. Solomon T.P., Haus J.M., Kelly K.R., Cook M.D., Riccardi M., Rocco M., et al. Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans. Am J Clin Nutr 2009, 90:1222-1229.
63. Schulze M.B., Manson J.E., Ludwig D.S., Colditz G.A., Stampfer M.J., Willett W.C., et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004, 292:927-934.
64. Dhingra R., Sullivan L., Jacques P.F., Wang T.J., Fox C.S., Meigs J.B., et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007, 116:480-488.
65. Montonen J., Järvinen R., Knekt P., Heliövaara M., Reunanen A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 2007, 137:1447-1454.
66. Palmer J.R., Boggs D.A., Krishnan S., Hu F.B., Singer M., Rosenberg L. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med 2008, 168:1487-1492.
67. Bazzano L.A., Joshipura K.J., Li T.Y., Hu F.B. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 2008, 31:1311-1317.
68. Odegaard A.O., Koh W.P., Arakawa K., Yu M.C., Pereira M.A. Soft drink and juice consumption and risk of physician-diagnosed incident type 2 diabetes: the Singapore Chinese Health Study. Am J Epidemiol 2010, 171:701-708.
69. Atkinson F.S., Foster-Powell K., Brand-Miller J.C. International tables of glycemic index and glycemic load values: 2008. Diabetes Care 2008, 31:2281-2283.
70. Sievenpiper J.L., Kendall C.W.C., Esfahani A., Wong J.M.W., Carleton A.J., Jiang H.Y., et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomized controlled experimental trials in people with and without diabetes. Diabetologia 2009, 52:1479-1495.
71. Salmerón J., Hu F.B., Manson J.E., Stampfer M.J., Colditz G.A., Rimm E.B., et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019-1026.
72. Meyer K.A., Kushi L.H., Jacobs D.R., Folsom A.R. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001, 24:1528-1535.
73. van Dam R.M., Willett W.C., Rimm E.B., Stampfer M.J., Hu F.B. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25:417-424.
74. Harding A.H., Day N., Shaw K.T., Bingham S., Luben R., Welsh A., et al. Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of Cancer-Norfolk study. Am J Epidemiol 2004, 159:73-82.
75. Halton T.L., Liu S., Manson J.E., Hu F.B. Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr 2008, 87:339-346.
76. Tinker L.F., Bonds D.E., Margolis K.L., Manson J.E., Howard B.V., Larson J., et al. Women's Health Initiative. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med 2008, 168:1500-1511.
77. Willett W.C., Leibel R.L. Dietary fat is not a major determinant of body fat. Am J Med 2002, 113(Suppl. 9B):47S-59S.
78. Samaha F.F., Iqbal N., Seshadri P., Chicano K.L., Daily D.A., McGrory J., et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003, 348:2074-2081.
79. Foster G.D., Wyatt H.R., Hill J.O., McGuckin B.G., Brill C., Mohammed B.S., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003, 348:2082-2090.
80. Gardner C.D., Kiazand A., Alhassan S., Kim S., Stafford R.S., Balise R.R., et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 2007, 297:969-977.
81. Shai I., Schwarzfuchs D., Henkin Y., Shahar D.R., Witkow S., Greenberg I., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008, 359:229-241.
82. Sacks F.M., Bray G.A., Carey V.J., Smith S.R., Ryan D.H., Anton S.D., et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009, 360:859-873.
83. Hession M., Rolland C., Kulkarni U., Wise A., Broom J. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev 2009, 10:36-50.
84. Brinkworth G.D., Noakes M., Buckley J.D., Keogh J.B., Clifton P.M. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr 2009, 90:23-32.
85. Krauss R.M. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 2005, 25:2265-2272.
86. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000, 71:412-433.
87. McAuley K., Mann J. Nutritional determinants of insulin resistance. J Lipid Res 2006, 47:1668-1676.
88. Haffner S.M. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol 2002, 90:55i-61i.
89. Lopez-Miranda J., Williams C., Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007, 98:458-473.
90. Hu F.B., van Dam R.M., Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001, 44:805-817.
91. Schulze M.B., Manson J.E., Willett W.C., Hu F.B. Processed meat intake and incidence of type 2 diabetes in younger and middle-aged women. Diabetologia 2003, 46:1465-1473.
92. Song Y.Q., Manson J.E., Buring J.E., Liu S. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women. The Women's Health Study. Diabetes Care 2004, 27:2108-2115.
93. Hodge A.M., English D.R., O'Dea K., Sinclair A.J., Makrides M., Gibson R.A., et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007, 86:189-197.
94. Thanopoulou A.C., Karamanos B.G., Angelico F.V., Assaad-Khalil S.H., Barbato A.F., del Ben M.P., et al. Dietary fat intake as risk factor for the development of diabetes: multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD). Diabetes Care 2003, 26:302-307.
95. van de Laar F., van de Lisdonk E., Lucassen P., Tigchelaar J., Meyboom S., Mulder J., et al. Fat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice. Br J Gen Pract 2004, 54:177-182.
96. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008, 47:348-380.
97. Babio N., Sorlí M., Bulló M., Basora J., Ibarrola-Jurado N., Fernández-Ballart J., et al. on behalf of the Nureta-PREDIMED investigators. Association between red meat consumption and metabolic syndrome in a Mediterranean population at high cardiovascular risk: cross-sectional and 1-year follow-up assessment. Nutr Metab Cardiovasc Dis 2010 Sep 26, [Epub ahead of print].
98. Micha R., Wallace S.K., Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus. A systematic review and meta-analysis. Circulation 2010, 121:2271-2283.
99. Iggman D., Arnlöv J., Vessby B., Cederholm T., Sjögren P., Risérus U. Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia 2010, 53:850-857.
100. van Woudenber G.J., van Ballegooijen A.J., Kuijstein A., Sijbrands E.J.G., van Rooij F.J.A., Geleijnse J.M., et al. Eating fish and risk of type 2 diabetes: a population-based, prospective follow-up study. Diabetes Care 2009, 32:2021-2026.
101. Kaushik M., Mozaffarian D., Spiegelman D., Manson J.E., Willett W.C., Hu F.B. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 2009, 90:613-620.
102. Patel P.S., Sharp S.J., Luben R.N., Khaw K.T., Bingham S.A., Wareham N.J., et al. Association between type of dietary fish and seafood intake and the risk of incident type 2 diabetes: the European prospective investigation of cancer (EPIC)-Norfolk cohort study. Diabetes Care 2009, 32:1857-1863.
103. Djoussé L., Gaziano J.M., Buring J.E., Lee I.M. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 2011, 93:143-150.
104. Brunham L.R., Kruit J.K., Verchere C.B., Hayden M.R. Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest 2008, 118:403-408.
105. Djoussé L., Gaziano J.M., Buring J.E., Lee I.M. Egg consumption and risk of type 2 diabetes in men and women. Diabetes Care 2009, 32:295-300.
106. Shi Z., Yuan B., Zhang C., Zhou M., Holmboe-Ottesen G. Egg consumption and the risk of diabetes in adults, Jiangsu, China. Nutrition 2011, 27:194-198.
107. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., Eckfeldt J.H. ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003, 78:91-98.
108. Sala-Vila A., Cofán M., Mateo-Gallego R., Cenarro A., Civeira F., Ortega E., et al. Inverse association between serum phospholipid oleic acid and insulin resistance in subjects with primary dyslipidaemia. Clin Nutr 2011 Mar 30, [Epub ahead of print].
109. Mozaffarian D., Aro A., Willett W.C. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009, 63:S5-S21.
110. Summers L.K., Fielding B.A., Bradshaw H.A., Ilic V., Beysen C., Clark M.L., et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002, 45:369-377.
111. Vessby B., Uusitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 2001, 44:312-319.
112. Lovejoy J.C., Smith S.R., Champagne C.M., Most M.M., Lefevre M., DeLany J.P., et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002, 25:1283-1288.
113. Tierney A.C., Roche H.M. The potential role of olive oil-derived MUFA in insulin sensitivity. Mol Nutr Food Res 2007, 251:1235-1248.
114. Tierney A.C., McMonagle J., Shaw D.I., Gulseth H.L., Helal O., Saris W.H., et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond) 2010 Oct 12, [Epub ahead of print].
115. Griffin M.D., Sanders T.A., Davies I.G., Morgan L.M., Millward D.J., Lewis F., et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006, 84:1290-1298.
116. Kabir M., Skurnik G., Naour N., Pechtner V., Meugnier E., Rome S., et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 2007, 86:1670-1679.
117. Mostad I.L., Bjerve K.S., Bjorgaas M.R., Lydersen S., Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006, 84:540-550.
118. Tardy A.L., Lambert-Porcheron S., Malpuech-Brugere C., Giraudet C., Rigaudiere J.P., Laillet B., et al. Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. Am J Clin Nutr 2009, 90:88-94.
119. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998, 67:577S-582S.
120. Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003, 78:617S-625S.
121. Beysen C., Karpe F., Fielding B.A., Clark A., Levy J.C., Frayn K.N. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 2002, 45:1533-1541.
122. Thomsen C., Storm H., Holst J.J., Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 response in patients with type 2 diabetes. Am J Clin Nutr 2003, 77:605-611.
123. López S., Bermúdez B., Pacheco Y.M., Villar J., Abia R., Muriana F.J. Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 2008, 88:638-644.
124. Rojo-Martinez G., Esteva I., Ruiz de Adana M.S., Garcia-Almeida J.M., Tinahones F., Cardona F., et al. Dietary fatty acids and insulin secretion: a population-based study. Eur J Clin Nutr 2006, 60:1195-1200.
125. Unger R.H. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003, 144:5159-5165.
126. Savage D.B., Petersen K.F., Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007, 87:507-520.
127. Poitout V., Amyot J., Semache M., Zarrouki B., Hagman D., Fontés G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 2010, 1801:289-298.
128. Joly E., Dbaibo G., Rosenberg L., Prentki M. Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology 2003, 144:4154-4163.
129. Gaster M., Rustan A.C., Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 2005, 54:648-656.
130. Lee J.S., Pinnamaneni S.K., Eo S.J., Cho I.H., Pyo J.H., Kim C.K., et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 2006, 100:1467-1474.
131. Perez-Martinez P., Perez-Jimenez F., Lopez-Miranda J. n-3 PUFA and lipotoxicity. Biochim Biophys Acta 2010, 1801:362-366.
132. Corcoran M.P., Lamon-Fava S., Ra Fielding Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr 2007, 85:662-677.
133. Storlien L.H., Pan D.A., Kriketos A.D., O'Connor J., Caterson I.D., Cooney G.J., et al. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996, 31(Suppl.):S261-S265.
134. Clarke S.D. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 2004, 15:13-18.
135. van Dam R.M., Feskens E.J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002, 360:1477-1478.
136. van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005, 294:97-104.
137. Huxley R., Lee C.M.Y., Barzi F., Timmermeister L., Czernichow S., Perkovic V., et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009, 169:2053-2063.
138. van Dam R.M. Coffee and type 2 diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis 2006, 16:69-77.
139. Campos H., Baylin A. Coffee consumption and risk of type 2 diabetes and heart disease. Nutr Rev 2007, 65:173-179.
140. Jing Y., Han G., Hu Y., Bi Y., Li L., Zhu D. Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med 2009, 24:557-562.
141. Baliunas D.O., Taylor B.J., Irving H., Roerecke M., Patra J., Mohapatra S., et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009, 32:2123-2132.
142. Tremblay A., Gilbert J.A. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009, 28(Suppl. 1):91S-102S.
143. Elwood P.C., Givens D.I., Beswick A.D., Fehily A.M., Pickering J.E., Gallacher J. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr 2008, 27:723S-734S.
144. Liu S., Choi H.K., Ford E., Song Y., Klevak A., Buring J.E., et al. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 2006, 29:1579-1584.
145. Choi H.K., Willett W.C., Stampfer M.J., Rimm E., Hu F.B. Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 2005, 165:997-1003.
146. Hamer M., Chida Y. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-analysis. J Hypertens 2007, 25:2361-2369.
147. Ros E., Mataix J. Fatty acid composition of nuts - implications for cardiovascular health. Br J Nutr 2006, 96(Suppl. 2):S29-S35.
148. Ros E., Tapsell L.C., Sabaté J. Nuts and berries for heart health. Curr Atheroscler Rep 2010, 12:397-406.
149. Jiang R., Manson J.E., Stampfer M.J., Liu S., Willett W.C., Hu F.B. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 2002, 288:2554-2560.
150. Kochar J., Gaziano J.M., Djoussé L. Nut consumption and risk of type II diabetes in the Physicians' Health Study. Eur J Clin Nutr 2010, 64:75-79.
151. Jenkins D.J.A., Hu F.B., Tapsell L.C., Josse A.R., Kendall C.W.C. Possible benefit of nuts in type 2 diabetes. J Nutr 2008, 138. 1752S-6S.
152. Casas-Agustench P., López-Uriarte P., Bulló M., Ros E., Cabré-Vila J.J., Salas-Salvadó J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009 Dec 21, [Epub ahead of print].
153. Li T.Y., Brennan A.M., Wedick N.M., Mantzoros C., Rifai N., Hu F.B. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 2009, 139:1333-1338.
154. Djoussé L., Gaziano J.M. Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study. Am J Clin Nutr 2008, 87:964-969.
155. Hu F.B., Stampfer M.J., Rimm E.B., MansonJE Ascherio A., Colditz G.A., et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999, 281:1387-1394.
156. Houston D.K., Ding J., Lee J.S., Garcia M., Kanaya A.M., Tylavsky F.A., et al. Dietary fat and cholesterol and risk of cardiovascular disease in older adults: the Health ABC Study. Nutr Metab Cardiovasc Dis 2010 Mar 23, [Epub ahead of print].
157. Mutungi G., Ratliff J., Puglisi M., Torres-Gonzalez M., Vaishnav U., Leite J.O., et al. Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. J Nutr 2008, 138:272-276.
158. Jacobs D.R., Gross M.D., Tapsell L.C. Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr 2009, 89(suppl.):1543S-1548S.
159. Trichopoulos D., Lagiou P. Mediterranean diet and cardiovascular epidemiology. Eur J Epidemiol 2004, 19:7-8.
160. Hu F.B., Rimm E., Smith-Warner S.A., Feskanich D., Stampfer M.J., Ascherio A., et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999, 69:243-249.
161. Martínez-González M.A., de la Fuente-Arrillaga C., Nunez-Cordoba J.M., Basterra-Gortari F.J., Beunza J.J., Vazquez Z., et al. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 2008, 336:1348-1351.
162. Mozaffarian D., Kamineni A., Carnethon M., Djoussé L., Mukamal K.J., Siscovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: the Cardiovascular Health study. Arch Intern Med 2009, 169:798-807.
163. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
164. Estruch R., Martínez-González M.A., Corella D., Salas-Salvadó J., Ruiz-Gutiérrez V., Covas M.I. Fiol; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11.
165. Salas-Salvadó J., Fernández-Ballart J., Ros E., Martínez-González M.A., Fitó M., Estruch R., et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008, 168:2449-2458.
166. Esposito K., Maiorino M.I., Ciotola M., Di Palo C., Scognamiglio P., Gicchino M., et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 2009, 151:306-314. Erratum in: Ann Intern Med 2009;151:591.
167. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
168. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
169. Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 2007, 65(12 Pt 2):S152-S156.
170. Spranger J., Kroke A., Möhlig M., Bergmann M.M., Ristow M., Boeing H., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
171. Duncan B.B., Schmidt M.I., Pankow J.S., Bang H., Couper D., Ballantyne C.M., et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in Communities study. Diabetes 2004, 53:2473-2478.
172. Wannamethee S.G., Lowe G.D., Rumley A., Cherry L., Whincup P.H., Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007, 30:1200-1205.
173. Kolberg J.A., Jørgensen T., Gerwien R.W., Hamren S., McKenna M.P., Moler E., et al. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 2009, 32:1207-1212.
174. Salomaa V., Havulinna A., Saarela O., Zeller T., Jousilahti P., Jula A., et al. Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 2010, 5:e10100.
175. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002, 51:1596-1600.
176. Thorand B., Lowel H., Schneider A., Kolb H., Meisinger C., Fröhlich M., et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the Monica Augsburg cohort study, 1984-1998. Arch Intern Med 2003, 163:93-99.
177. Sattar N., Wannamethee S.G., Forouhi N.G. Novel biochemical risk factors for type 2 diabetes: Pathogenic insights or prediction possibilities?. Diabetologia 2008, 51:926-940.
178. Hennige A.M., Stefan N., Kapp K., Lehmann R., Weigert C., Beck A., et al. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J 2006, 20:1206-1208.
179. Meigs J.B., Hu F.B., Rifai N., Manson J.E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004, 291:1978-1986.
180. Selvin E., Paynter N.P., Erlinger T.P. The effect of weight loss on C-reactive protein. A systematic review. Arch Intern Med 2007, 167:31-39.
181. Basu A., Devaraj S., Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 2006, 26:995-1001.
182. Giugliano D., Ceriello A., Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006, 48:677-685.
183. Bulló M., Casas-Agustench P., Amigó-Correig P., Aranceta J., Salas-Salvadó J. Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr 2007, 10(10A):1164-1172.
184. Hanhineva K., Törrönen R., Bondia-Pons I., Pekkinen J., Kolehmainen M., Mykkänen H., et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11:1365-1402.
185. Dickinson S., Hancock D.P., Petocz P., Ceriello A., Brand-Miller J. High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. Am J Clin Nutr 2008, 87:1188-1193.
186. Montori V.M., Farmer A., Wollan P.C., Dinneen S.F. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000, 23:1407-1415.
187. Levitan E.B., Cook N.R., Stampfer M.J., Ridker P.M., Rexrode K.M., Buring J.E., et al. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism 2008, 57:437-443.
188. Du H., van der A.D.L., van Bakel M.M., van der Kallen C.J., Blaak E.E., van Greevenbroek M.M., et al. Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. Am J Clin Nutr 2008, 87:655-661.
189. Jiang R., Jacobs D.R., Mayer-Davis E., Szklo M., Herrington D., Jenny N.S., et al. Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006, 163:222-231.
190. Fung T.T., McCullough M.L., Newby P.K., Manson J.E., Meigs J.B., Rifai N., et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2005, 82:163-173.
191. Mantzoros C.S., Williams C.J., Manson J.E., Meigs J.B., Hu F.B. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 2006, 84:328-335.
192. Mena M.P., Sacanella E., Vazquez-Agell M., Morales M., Fitó M., Escoda R., et al. Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr 2009, 89:248-256.
193. van Dam R.M., Rimm E.B., Willett W.C., Stampfer M.J., Hu F.B. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002, 136:201-209.
194. Fung T.T., Schulze M., Manson J.E., Willett W.C., Hu F.B. Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med 2004, 164:2235-2240.
195. Montonen J., Knekt P., Härkänen T., Järvinen R., Heliövaara M., Aromaa A., et al. Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol 2005, 161:219-227.
196. Heidemann C., Hoffmann K., Spranger J., Klipstein-Grobusch K., Möhlig M., Pfeiffer A.F., et al. European prospective investigation into cancer and nutrition (EPIC)-Potsdam study cohort. A dietary pattern protective against type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)-Postdam study cohort. Diabetologia 2005, 48:1126-1134.
197. Brunner E.J., Mosdøl A., Witte D.R., Martikainen P., Stafford M., Shipley M.J., et al. Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality. Am J Clin Nutr 2008, 87:1414-1421.
198. Nettleton J.A., Steffen L.M., Ni H., Liu K., Jacobs D.R. Dietary patterns and risk of incident type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2008, 31:1777-1782.
199. Liese A.D., Weis K.E., Schulz M., Tooze J.A. Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2009, 32:263-268.
200. Mozaffarian D., Marfisi R., Levantesi G., Silletta M.G., Tavazzi L., Tognoni G., et al. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 2007, 370:667-675.